Methylenetetrahydrofolate reductase thermolabile variant and oral clefts

American Journal of Medical Genetics

Volumn 86, Issue 1, 1999, Pages 71-74

  Mills, James L ^a,e   Kirke, Peadar N ^b   Molloy, Anne M ^c   Burke, Helen ^b   Conley, Mary R ^a   Lee, Young Jack ^a   Mayne, Philip D ^d   Weir, Donald G ^c   Scott, John M ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HEALTH RESEARCH BOARD   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d Temple Street Children's Hospital   (Ireland)

^e Epidemiology Branch DESPR   (United States)

Author keywords

Birth defect; Cleft lip; Cleft palate; Folate; Genetic defect; Metabolic defect

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; FOLIC ACID;

ARTICLE; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; GENE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRIORITY JOURNAL;

CHILD; CLEFT LIP; CLEFT PALATE; ENZYME STABILITY; FAMILY HEALTH; FEMALE; FOLIC ACID; GENE FREQUENCY; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; IRELAND; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; TEMPERATURE;

EID: 0032802054     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990903)86:1<71::AID-AJMG14>3.0.CO;2-Y     Document Type: Article

References (18)

1. Bower C, Stanley FJ. 1992. Dietary folate and nonneural midline birth defects: no evidence of an association from a case-control study in Western Australia. Am J Med Genet 44:647-650.
2. Conway H. 1958. Effect of supplemental vitamin therapy on the limitation of incidence of cleft lip and cleft palate in humans. Plast Reconstr Surg 22:450-453.
3. Czeizel AE. 1993. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 306:1645-1648.
4. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. 1997. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350:1666-1669.
5. Eurocat Working Group. 1997. Fifteen years of surveillance of congenital anomalies in Europe, 1980-1994. Eurocat report. Brussels: Scientific Institute of Public Health-Louis Pasteur. p 48-92.
6. Hayes C, Werler MM, Willett WC, Mitchell AA. 1996. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 143:1229-1234.
7. Hill L, Murphy M, McDowall M, Paul AH. 1988. Maternal drug histories and congenital malformations: limb reduction defects and oral clefts. J Epidemiol Community Health 42:1-7.
8. Khoury MJ, Gomez-Farias M, Mulinare J. 1989. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? Am J Dis Child 143:333-337.
9. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, Conley M, Whitehead AS, Weir DG, Scott JM. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
10. Peer LA, Gordon HW, Bernhard WG. 1964. Effect of vitamins on human teratology. Plast Reconstr Surg 34:358-362.
11. Saxen I. 1975. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 4:37-44.
12. Schubert J, Schmidt R, Raupach HW. 1990. New findings explaining the mode of action in prevention of facial clefting and first clinical experience. J Craniomaxillofac Surg 18:343-347.
13. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. 1995. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346:393-396.
14. Shaw GM, Rozen R, Finell RH, Todoroff K, Lammer EJ. 1998. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use and cleft lip. Am J Med Genet 80:196-198.
15. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS. 1999. The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
16. Tolarova M, Harris J. 1995. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51:71-78.
17. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
18. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.